Medtronic, Inc. (MDT) Reports Q4 EPS of 90c, Misses by 3c
May 24, 2011 7:16 AM
Medtronic, Inc. (NYSE: MDT) reported Q4 EPS of $0.90, ex-items, $0.03 worse than the analyst estimate of $0.93. Revenue for the quarter came in at $4.3 billion versus the consensus estimate of $4.29 billion.
Sales from the company's Cardiac and Vascular unit totaled $2.322 billion. Sales from the CRDM segment were $1.32 billion, down about 9 percent year-over-year.
